Autosomal dominant hypophosphatemic rickets
Autosomal dominant hypophosphatemic rickets (ADHR) is a rare genetic disorder characterized by rickets and osteomalacia due to renal phosphate wasting. This condition is inherited in an autosomal dominant manner, meaning a single copy of the mutated gene can cause the disorder.
Genetics[edit | edit source]
ADHR is caused by mutations in the FGF23 gene, which encodes the protein fibroblast growth factor 23. This protein plays a crucial role in regulating phosphate homeostasis. Mutations in FGF23 lead to increased activity of the protein, resulting in reduced phosphate reabsorption in the kidneys and decreased levels of active vitamin D.
Clinical Features[edit | edit source]
Patients with ADHR typically present with symptoms of rickets, such as bone pain, skeletal deformities, and growth retardation. In adults, the condition can lead to osteomalacia, which is characterized by softening of the bones, leading to fractures and bone pain. Other symptoms may include muscle weakness and fatigue.
Diagnosis[edit | edit source]
The diagnosis of ADHR is based on clinical evaluation, biochemical tests, and genetic testing. Biochemical tests typically show low serum phosphate levels, elevated levels of alkaline phosphatase, and inappropriately normal or low levels of 1,25-dihydroxyvitamin D. Genetic testing can confirm the diagnosis by identifying mutations in the FGF23 gene.
Treatment[edit | edit source]
The treatment of ADHR focuses on managing symptoms and correcting phosphate levels. This often involves oral phosphate supplements and active vitamin D analogs, such as calcitriol. Regular monitoring of serum phosphate and calcium levels is essential to avoid complications such as hypercalcemia and nephrocalcinosis.
Prognosis[edit | edit source]
The prognosis for individuals with ADHR varies. Early diagnosis and appropriate treatment can improve symptoms and prevent complications. However, some patients may continue to experience bone pain and fractures despite treatment.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
-
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD